Patterns of Fine Needle Aspiration Cytology Diagnosed Thyroid Nodules Among Clinically Suspected Patients in Northeast Ethiopia

References

• Mulita F, Anjum F. Thyroid adenoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from http://www.ncbi.nlm.nih.gov/books/NBK56225.
   Google Scholar
• Carling T, Udelsman R. Thyroid cancer. Annu Rev Med. 2014;65(1):125–137. doi:10.1146/annurev-med-061512-105739
   PubMed Web of Science ®Google Scholar
• Bailey S, Wallwork B. Differentiating between benign and malignant thyroid nodules: an evidence-based approach in general practice. Aust J Gen Pract. 2018;47(11):770–774. doi:10.31128/AJGP-03-18-4518
   PubMed Web of Science ®Google Scholar
• Zhang Z, Reiding KR, Wu J, Li Z, Xu X. Distinguishing benign and malignant thyroid nodules and identifying lymph node metastasis in papillary thyroid cancer by plasma N-glycomics. Front Endocrinol. 2021;12:692910. doi:10.3389/fendo.2021.692910
   PubMed Web of Science ®Google Scholar
• Choi YJ, Jung I, Min SJ, et al. Thyroid nodule with benign cytology: is clinical follow-up enough? PLoS One. 2013;8(5):e63834. doi:10.1371/journal.pone.0063834
   PubMed Web of Science ®Google Scholar
• Kim M. Study of natural history of benign thyroid nodules shows only rare progression to cancer. Oncology Times. 2015;37(10):78–79. doi:10.1097/01.COT.0000466408.71686.15
   Google Scholar
• Muhammad H, Santhanam P, Russell JO, Kuo JH. RFA and benign thyroid nodules: review of the current literature. Laryngosc Investig Otolaryngol. 2021;6(1):155–165. doi:10.1002/lio2.517
   PubMed Web of Science ®Google Scholar
• Takano T. Natural history of thyroid cancer. Endocr J. 2017;64(3):237–244. doi:10.1507/endocrj.EJ17-0026
   PubMed Web of Science ®Google Scholar
• Khosravi MH, Kouhi A, Saeedi M, Bagherihagh A, Amirzade-Iranaq MH. Thyroid cancers: considerations, classifications, and managements. In: Akarslan Z, editor. Diagnosis and Management of Head and Neck Cancer. InTech; 2017. doi:10.5772/intechopen.70128
   Google Scholar
• Buffet C, Groussin L. Molecular perspectives in differentiated thyroid cancer. Annales D’ Endocrinologie. 2015;76(1):1S8–15. doi:10.1016/S0003-4266(16)30009-9
   PubMedGoogle Scholar
• Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on fundamental mechanisms of thyroid cancer. Front Endocrinol. 2020;11:102. doi:10.3389/fendo.2020.00102
   PubMed Web of Science ®Google Scholar
• Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154(6):1420–1427. doi:10.1016/j.surg.2013.07.006
   PubMed Web of Science ®Google Scholar
• Katoh H, Yamashita K, Enomoto T, Watanabe M. Classification and general considerations of thyroid cancer. Ann Clin Pathol. 2015;3(1):1045.
   Google Scholar
• Fagin JA, Wells SA. Biologic and clinical perspectives on thyroid cancer. N Engl J Med. 2016;375(11):1054–1067. doi:10.1056/NEJMra1501993
   PubMed Web of Science ®Google Scholar
• Crippa S, Cibas ES, Mazzucchelli L, Ali SZ. The Bethesda system for reporting thyroid fine-needle aspiration specimens. Am J Clin Pathol. 2010;134(2):343–345. doi:10.1309/AJCPXM9WIRQ8JZBJ
   PubMed Web of Science ®Google Scholar
• Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–1165. doi:10.1089/thy.2009.0274
   PubMed Web of Science ®Google Scholar
• Kafle N, Koirala B, Kafle S, Singh M, Sinha A. Cytopathological evaluation of thyroid lesions based on Bethesda system in patients attending Birat Medical College and Teaching Hospital. Nep Med Coll J. 2020;22(4):260–265. doi:10.3126/nmcj.v22i4.34194
   Google Scholar
• Mulita F, Plachouri MK, Liolis E, Vailas M, Panagopoulos K, Maroulis I. Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS). Endokrynol Pol. 2021;72(2):143–144. doi:10.5603/EP.a2021.0018
   PubMed Web of Science ®Google Scholar
• Masereka R, Okeny PK, Fualal JO, Wamala D. Diagnostic accuracy of fine needle aspiration cytology in patients undergoing thyroidectomy in Uganda: tertiary hospital experience. Afr Healt Sci. 2017;16(4):1143. doi:10.4314/ahs.v16i4.32
   Web of Science ®Google Scholar
• Bible KC, Kebebew E, Brierley J, et al. American Thyroid Association anaplastic thyroid cancer guidelines task force. Thyroid. 2021;31(3):337–386. doi:10.1089/thy.2020.0944
   PubMed Web of Science ®Google Scholar
• Rahimi M, Farshchian N, Rezaee E, Shahebrahimi K, Madani H. To differentiate benign from malignant thyroid nodule comparison of sonography with FNAC findings. Pak J Med Sci. 2013;29(1):77–80. doi:10.12669/pjms.291.2595
   PubMed Web of Science ®Google Scholar
• Lingam RK, Qarib MH, Tolley NS. Evaluating thyroid nodules: predicting and selecting malignant nodules for fine-needle aspiration (FNA) cytology. Insights Imaging. 2013;4(5)::617–24. doi:10.1007/s13244-013-0256-6
   PubMedGoogle Scholar
• Middleton WD, Teefey SA, Tessler FN, et al. Analysis of malignant thyroid nodules that do not meet ACR TI-RADS criteria for fine-needle aspiration. Am J Roentgenol. 2021;216(2):471–478. doi:10.2214/AJR.20.23123
   PubMed Web of Science ®Google Scholar
• Shen Y, Liu M, He J, et al. Comparison of different risk-stratification systems for the diagnosis of benign and malignant thyroid nodules. Front Oncol. 2019;9:378. doi:10.3389/fonc.2019.00378
   PubMed Web of Science ®Google Scholar
• Yan H-X, Pang P, Wang F-L. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000–2013 in China: a retrospective study. Sci Rep. 2017;7(1):15832. doi:10.1038/s41598-017-14963-z
   PubMedGoogle Scholar
• Yaprak Bayrak B, Eruyar AT. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology. BMC Endocr Disord. 2020;20(1):48. doi:10.1186/s12902-020-0530-9
   PubMed Web of Science ®Google Scholar
• Yoo WS, Ahn HY, Ahn HS, et al. Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype. Medicine. 2020;99(2):e18780. doi:10.1097/MD.0000000000018780
   PubMed Web of Science ®Google Scholar
• Zhao H, Guo H, Zhao L, et al. Subclassification of the Bethesda Category III (AUS/FLUS): a study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China. Cancer Cytopathol. 2021;129(8):642–648. doi:10.1002/cncy.22417
   PubMed Web of Science ®Google Scholar
• Ozdemi A, Uyan M, Kalcan S, Çolakoğlu MK, Pergel A. Malignancy rates and risk factors in Bethesda category IV thyroid nodules: is lobectomy enough in an endemic region? J Exp Clin Med. 2022;39(3):749–754. doi:10.52142/omujecm.39.3.30
   Google Scholar
• Gregory A, Bayat M, Kumar V, et al. Differentiation of benign and malignant thyroid nodules by using comb-push ultrasound shear elastography. Acad Radiol. 2018;25(11):1388–1397. doi:10.1016/j.acra.2018.02.025
   PubMed Web of Science ®Google Scholar
• Hong MJ, Na DG, Baek JH, Sung JY, Kim JH. Impact of nodule size on malignancy risk differs according to the ultrasonography pattern of thyroid nodules. Korean J Radiol. 2018;19(3):534–541. doi:10.3348/kjr.2018.19.3.534
   PubMed Web of Science ®Google Scholar
• Rago T, Fiore E, Scutari M, et al. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol. 2010;162(4):763–770. doi:10.1530/EJE-09-0895
   PubMed Web of Science ®Google Scholar
• Paulson VA, Rudzinski ER, Hawkins DS. Thyroid cancer in the pediatric population. Genes. 2019;10(9):723. doi:10.3390/genes10090723
   PubMed Web of Science ®Google Scholar
• Lim-Dunham JE, Erdem Toslak I, Alsabban K, et al. Ultrasound risk stratification for malignancy using the 2015 American Thyroid Association Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Pediatr Radiol. 2017;47(4):429–436. doi:10.1007/s00247-017-3780-6
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.0020
   PubMed Web of Science ®Google Scholar
• Creo A, Alahdab F, Al Nofal A, Thomas K, Kolbe A, Pittock ST. Ultrasonography and the American Thyroid Association ultrasound-based risk stratification tool: utility in pediatric and adolescent thyroid nodules. Horm Res Paediatr. 2018;90(2):93–101. doi:10.1159/000490468
   PubMed Web of Science ®Google Scholar
• Porterfield JR, Grant CS, Dean DS, et al. Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery. 2008;144(6):963–969. doi:10.1016/j.surg.2008.09.006
   PubMed Web of Science ®Google Scholar
• Pinchot SN, Al-Wagih H, Schaefer S, Sippel R, Chen H. Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger. Arch Surg. 2009;144(7):649–665. doi:10.1001/archsurg.2009.116
   PubMedGoogle Scholar
• McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, Yim JH. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery. 2007;142(6):837–844.e3. doi:10.1016/j.surg.2007.08.012
   PubMed Web of Science ®Google Scholar
• Fornwalt B, Melachuri M, Kubina M, McDaniel J, Jeyakumar A. Pediatric thyroid nodules: ultrasound characteristics as indicators of malignancy. OTO Open. 2022;6(1):24 739 74X 2110737. doi:10.1177/2473974X211073702
   Google Scholar
• Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA. 2017;317(13):1338. doi:10.1001/jama.2017.2719
   PubMed Web of Science ®Google Scholar